A retrospective study assessing real world healthcare resource utilization (HCRU) and subsequent costs in Multiple Myeloma patients in the United States
Latest Information Update: 15 Jun 2022
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
Most Recent Events
- 15 Jun 2022 New trial record
- 18 May 2022 Results presented at the 27th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research